-
MAXCYTE INC NASDAQ:MXCT MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.
Location: 22 Firstfield Rd Ste 110, Maryland, 20878-1795, US | Website: https://www.maxcyte.com/ | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
246.9M
Cash
157.3M
Avg Qtr Burn
-5.664M
Short % of Float
4.01%
Insider Ownership
1.45%
Institutional Own.
70.51%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|